Menarini Asia Pacific Holdings Ptd Ltd

Menarini Asia-Pacific is part of the world’s largest Italian biopharmaceutical company with a heritage since 1886 and over 17,000 employees in more than 130 countries. Here in Asia-Pacific, Menarini has an established presence in 13 key healthcare markets with over 3,400 sales, marketing and support professionals.
Supported by the Group’s R&D, Manufacturing and infrastructure capabilities, Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields including Consumer Health, Derma-Aesthetics, Primary Care, Allergy/Respiratory, Cardiovascular, Pain Management, Specialty Care and Men’s Health.
Menarini has a strong partnering tradition. As companies reprioritize portfolios and seek experienced partners to gain market access in this heterogeneous environment, Menarini is a trusted European partner who can be the gateway for companies that want to tap into the Asia-Pacific growth story.
Menairni Biomarkers was established to spearhead leading edge research and development efforts internationally. Menarini Biomarkers offers an unprecedented capability for R&D teams to study rare cells and determine the biological significance of distinct subpopulations of cells within a sample. With this knowledge, customers are developing new diagnostic and therapeutic strategies to improve patient outcomes and address unmet medical needs.

For more information about Menarini Asia-Pacific, please visit www.menariniapac.com